Vident Investment Advisory, LLC Personalis, Inc. Transaction History

Vident Investment Advisory, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$3.27 - $8.76 $34,805 - $93,241	-10,644 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$7.56 - $14.3 $16,435 - $31,088	-2,174 Reduced 16.96%	10,644 $87,000
Q4 2021 Feb 14, 2022	BUY	$12.24 - $21.25 $156,892 - $272,382	12,818 New	12,818 $183,000
Q3 2021 Nov 12, 2021	SELL	$16.69 - $26.05 $133,736 - $208,738	-8,013 Closed	0 $0
Q2 2021 Aug 13, 2021	BUY	$18.15 - $27.75 $145,435 - $222,360	8,013 New	8,013 $203,000

30.1M

27.5K

85.4K

Ticker PSNL
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 45,918,400
Market Cap $280M
Description
Personalis, Inc. operates as a cancer genomics company worldwide. The company provides sequencing and data analysis services to support the development of cancer therapies and large-scale genetic research programs. It offers NeXT Platform, which provides data analysis for tumor and its immune microenvironment, from a single limited tissue or pla...

Get notified when there are updates to the investment portfolio of Vident Investment Advisory, LLC, based on Form 13F filings with the SEC.

Stay updated on Vident Investment Advisory, LLC with notifications on news.